An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

ClinicalTrials.gov ID: NCT06951217

Public ClinicalTrials.gov record NCT06951217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Long-Term, Safety and Tolerability, Open-Label Extension Study of Subjects Who Have Participated in Avalyn Pharma Studies of Inhaled Antifibrotic Agents (AP-LTE-008 [SAIL])

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants will have their final dose of drug at the end of study visit from the lead-in study and first AP-LTE-008 study visit on the same day.

Study identification

NCT ID: NCT06951217
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Avalyn Pharma Inc.; Industry
Enrollment: 340 participants

Conditions and interventions

Conditions

Interventions

AP01 Combination Product

Combination Product

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 16, 2025
Primary completion: Dec 30, 2031
Completion: Dec 30, 2031
Last update posted: Aug 27, 2026

2025 – 2031

United States locations

U.S. sites: 27
U.S. states: 20
U.S. cities: 23

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35205	Recruiting
University of Southern California	Los Angeles	California	90033	Recruiting
University of Colorado, Anschutz Medical Campus	Aurora	Colorado	80045	Recruiting
Renstar Medical Research	Ocala	Florida	34470	Recruiting
Piedmont Healthcare, Inc.	Atlanta	Georgia	30309	Recruiting
The University of Kansas Medical Center	Kansas City	Kansas	66160	Recruiting
University of Maryland	Baltimore	Maryland	21201	Recruiting
Johns Hopkins Asthma and Allergy Center	Baltimore	Maryland	21205	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55901	Recruiting
Hannibal Regional Healthcare System, Inc.	Hannibal	Missouri	63401	Recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Recruiting
Columbia University	New York	New York	10032	Recruiting
Piedmont HealthCare, PA	Statesville	North Carolina	28625	Recruiting
Southeastern Research Center	Winston-Salem	North Carolina	27103	Recruiting
University of Cincinnati	Cincinnati	Ohio	45267	Recruiting
Summit Health	Bend	Oregon	97701	Recruiting
Thomas Jefferson University	Philadelphia	Pennsylvania	19107	Recruiting
Temple University Hospital	Philadelphia	Pennsylvania	19140	Recruiting
Lowcountry Lung and Critical Care, PA	Charleston	South Carolina	29406	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37204	Recruiting
El Paso Pulmonary Association, P.A.	El Paso	Texas	79902	Recruiting
Baylor College of Medicine	Houston	Texas	77030	Recruiting
Intermountain Medical Center	Murray	Utah	84107	Recruiting
University of Utah	Salt Lake City	Utah	84108	Recruiting
Inova Healthcare	Falls Church	Virginia	22042	Recruiting
University of Washington	Seattle	Washington	98195	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06951217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 27, 2026 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06951217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →